Forex
World
Market
Business
Cryptocurrency
Commodities
MAP
Publish for free
Business
financetom
/
Business
/
--Barrington Research Adjusts Perdoceo Education's PT to $30 From $37, Keeps Outperform Rating
News
World
Market
Environment
Technology
Personal Finance
Politics
Retail
Business
Economy
Cryptocurrency
Forex
Stocks Market
Commodities
--Barrington Research Adjusts Perdoceo Education's PT to $30 From $37, Keeps Outperform Rating
Aug 1, 2024 7:24 AM
10:12 AM EDT, 08/01/2024 (MT Newswires) --
Price: 24.65, Change: -0.14, Percent Change: -0.56
Previous page:
Why Bio-Path Holdings Shares Are Falling Today
Next page:
3M Board Approves Planned Spin-off of Health Care Business
Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Release time ⇩
Release time ⇧
Like count ⇩
Show More Comments
Related Articles >
Why Bio-Path Holdings Shares Are Falling Today
Mar 8, 2024
Bio-Path Holdings, Inc. ( BPTH ) shares are falling on Friday. The company reported fourth-quarter earnings per share of $4.23 loss, narrower than the estimate of $5.40 loss. Bio-Path ( BPTH ) reported a net loss of $33.63 per share for the year ended Dec. 31, 2023, lower than $38.12 per share in the year-ago period. Research and development expense for the...
3M Board Approves Planned Spin-off of Health Care Business
Mar 8, 2024
12:17 PM EST, 03/08/2024 (MT Newswires) -- 3M ( MMM ) said Friday its board approved the planned spin-off of its health care business, which will be known as Solventum. Solventum, expected to separate on April 1, has applied to list on the New York Stock Exchange under the SOLV ticker. 3M ( MMM ) shareholders will receive one share...
--Street Color: 3M Approves Spinoff of Health Care Business
Mar 8, 2024
12:21 PM EST, 03/08/2024 (MT Newswires) -- (Street Color news is derived from real time discussions with market professionals globally subscribed to the Street Color Premium Chat service on Bloomberg IB Chat and the ICE IM. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.) Price: 94.07, Change: +1.45, Percent...
What's Going On With Psyence Biomedical Stock?
Mar 8, 2024
Psyence Biomedical Ltd. ( PBM ) shares are racing higher Friday. The company recently announced its subsidiary, Psyence Australia, received Human Research Ethics Committee approval to initiate its Phase IIb study. The Details: On Wednesday, Psyence Biomedical ( PBM ) announced the approval for its Phase IIb study to examine the use of psilocybin as a treatment for Adjustment Disorder...
About
Terms and Conditions
Privacy policy
Cookie Settings
Contact Us
Services
Login
register
financetom
Market
Personal Finance
Business
Economy
Cryptocurrency
MAP
Links
zpostcode
Recruit
weather
mreligion
Yellowpages
sport
constellation
shopping
name
game
directory
literature
Word
tour
furnish
Lottery
tftnews
lyrics
News
digital
car
dir
Edu
Finance
Copyright 2023-2026 -
www.financetom.com
All Rights Reserved
News
World
Market
Environment
Technology
Personal Finance
Politics
Retail
Business
Economy
Cryptocurrency
MAP